|
1
|
Ronsin C, Muscatelli F, Mattei MG and
Breathnach R: A novel putative receptor protein tyrosine kinase of
the met family. Oncogene. 8:1195–1202. 1993.PubMed/NCBI
|
|
2
|
Zhao S, Ammanamanchi S, Brattain M, Cao L,
Thangasamy A, Wang J and Freeman JW: Smad4-dependent TGF-beta
signaling suppresses RON receptor tyrosine kinase-dependent
motility and invasion of pancreatic cancer cells. J Biol Chem.
283:11293–11301. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thangasamy A, Rogge J and Ammanamanchi S:
Recepteur d'origine nantais tyrosine kinase is a direct target of
hypoxia-inducible factor-1alpha-mediated invasion of breast
carcinoma cells. J Biol Chem. 284:14001–14010. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Logan-Collins J, Thomas RM, Yu P, Jaquish
D, Mose E, French R, Stuart W, McClaine R, Aronow B, Hoffman RM, et
al: Silencing of RON receptor signaling promotes apoptosis and
gemcitabine sensitivity in pancreatic cancers. Cancer Res.
70:1130–1140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iwama A, Okano K, Sudo T, Matsuda Y and
Suda T: Molecular cloning of a novel receptor tyrosine kinase gene,
STK, derived from enriched hematopoietic stem cells. Blood.
83:3160–3169. 1994.PubMed/NCBI
|
|
6
|
Yoshimura T, Yuhki N, Wang MH, Skeel A and
Leonard EJ: Cloning, sequencing, and expression of human macrophage
stimulating protein (MSP, MST1) confirms MSP as a member of the
family of kringle proteins and locates the MSP gene on chromosome
3. J Biol Chem. 268:15461–15468. 1993.PubMed/NCBI
|
|
7
|
Wang MH, Ronsin C, Gesnel MC, Coupey L,
Skeel A, Leonard EJ and Breathnach R: Identification of the ron
gene product as the receptor for the human macrophage stimulating
protein. Science. 266:117–119. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu Y, Yao HP and Wang MH: Multiple
variants of the RON receptor tyrosine kinase: Biochemical
properties, tumorigenic activities, and potential drug targets.
Cancer Lett. 257:157–164. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Collesi C, Santoro MM, Gaudino G and
Comoglio PM: A splicing variant of the RON transcript induces
constitutive tyrosine kinase activity and an invasive phenotype.
Mol Cell Biol. 16:5518–5526. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ghigna C, Giordano S, Shen H, Benvenuto F,
Castiglioni F, Comoglio PM, Green MR, Riva S and Biamonti G: Cell
motility is controlled by SF2/ASF through alternative splicing of
the Ron protooncogene. Mol Cell. 20:881–890. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bonomi S, di Matteo A, Buratti E, Cabianca
DS, Baralle FE, Ghigna C and Biamonti G: HnRNP A1 controls a
splicing regulatory circuit promoting mesenchymal-to-epithelial
transition. Nucleic Acids Res. 41:8665–8679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moon H, Cho S, Loh TJ, Oh HK, Jang HN,
Zhou J, Kwon YS, Liao DJ, Jun Y, Eom S, et al: SRSF2 promotes
splicing and transcription of exon 11 included isoform in Ron
proto-oncogene. Biochim Biophys Acta. 1839:1132–1140. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou YQ, He C, Chen YQ, Wang D and Wang
MH: Altered expression of the RON receptor tyrosine kinase in
primary human colorectal adenocarcinomas: Generation of different
splicing RON variants and their oncogenic potential. Oncogene.
22:186–197. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang MH, Kurtz AL and Chen Y:
Identification of a novel splicing product of the RON receptor
tyrosine kinase in human colorectal carcinoma cells.
Carcinogenesis. 21:1507–1512. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen YQ, Zhou YQ, Angeloni D, Kurtz AL,
Qiang XZ and Wang MH: Overexpression and activation of the RON
receptor tyrosine kinase in a panel of human colorectal carcinoma
cell lines. Exp Cell Res. 261:229–238. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Green MR: Pre-mRNA splicing. Annu Rev
Genet. 20:671–708. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Black DL: Mechanisms of alternative
pre-messenger RNA splicing. Annu Rev Biochem. 72:291–336. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Berglund JA, Chua K, Abovich N, Reed R and
Rosbash M: The splicing factor BBP interacts specifically with the
pre-mRNA branchpoint sequence UACUAAC. Cell. 89:781–787. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nelson KK and Green MR: Mammalian U2 snRNP
has a sequence-specific RNA-binding activity. Genes Dev.
3:1562–1571. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Isken O and Maquat LE: The multiple lives
of NMD factors: Balancing roles in gene and genome regulation. Nat
Rev Genet. 9:699–712. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chang YF, Imam JS and Wilkinson MF: The
nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem.
76:51–74. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Valacca C, Bonomi S, Buratti E, Pedrotti
S, Baralle FE, Sette C, Ghigna C and Biamonti G: Sam68 regulates
EMT through alternative splicing-activated nonsense-mediated mRNA
decay of the SF2/ASF proto-oncogene. J Cell Biol. 191:87–99. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saltzman AL, Kim YK, Pan Q, Fagnani MM,
Maquat LE and Blencowe BJ: Regulation of multiple core spliceosomal
proteins by alternative splicing-coupled nonsense-mediated mRNA
decay. Mol Cell Biol. 28:4320–4330. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma Q, Zhang K, Yao HP, Zhou YQ, Padhye S
and Wang MH: Inhibition of MSP-RON signaling pathway in cancer
cells by a novel soluble form of RON comprising the entire sema
sequence. Int J Oncol. 36:1551–1561. 2010.PubMed/NCBI
|
|
25
|
Gong Q, Zhang L, Vincent GM, Horne BD and
Zhou Z: Nonsense mutations in hERG cause a decrease in mutant mRNA
transcripts by nonsense-mediated mRNA decay in human long-QT
syndrome. Circulation. 116:17–24. 2007. View Article : Google Scholar : PubMed/NCBI
|
